ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
- Supplementary File 1:
PDF-Document (PDF, 253 KiB)
Sato, E.; Nakayama, K.; Razia, S.; Nakamura, K.; Ishikawa, M.; Minamoto, T.; Ishibashi, T.; Yamashita, H.; Iida, K.; Kyo, S. ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. Int. J. Mol. Sci. 2018, 19, 1710. https://doi.org/10.3390/ijms19061710
Sato E, Nakayama K, Razia S, Nakamura K, Ishikawa M, Minamoto T, Ishibashi T, Yamashita H, Iida K, Kyo S. ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. International Journal of Molecular Sciences. 2018; 19(6):1710. https://doi.org/10.3390/ijms19061710
Chicago/Turabian StyleSato, Emi; Nakayama, Kentaro; Razia, Sultana; Nakamura, Kohei; Ishikawa, Masako; Minamoto, Toshiko; Ishibashi, Tomoka; Yamashita, Hitomi; Iida, Kouji; Kyo, Satoru. 2018. "ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma" Int. J. Mol. Sci. 19, no. 6: 1710. https://doi.org/10.3390/ijms19061710